Registration Document

Overview

The report describes GenSight Biologics as a clinical-stage biotechnology company developing gene-therapy candidates GS010 and GS030 for retinal diseases, with GS010 in Phase III and GS030 in preclinical development. It reports 27 employees at December 31, 2016, all located in France. Environmental measurement focused on greenhouse-gas emissions from business travel.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2016
Period: Ends 31 December 2016
Publication date: 28 April 2017
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services